vimarsana.com
Home
Live Updates
Mendus provides business update and outlook for vididencel p
Mendus provides business update and outlook for vididencel p
Mendus provides business update and outlook for vididencel program
Press Release Stockholm, Sweden, March 12, 2024 ADVANCE II Phase 2 trial data provide basis for late-stage development of lead product vididencel in acute myeloid leukemiaRegistration trial...
Related Keywords
Sweden ,
Australia ,
United States ,
Netherlands ,
Stockholm ,
American ,
Australian ,
Erik Manting ,
Lymphoma Group ,
American Society For Hematology ,
Northx Biologics ,
Business Update ,
American Society ,
Australian Leukemia ,
Inderes Event Studio ,
Nasdaq Stockholm ,
Markets ,